Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring the most necessary information in a timely and concise format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focuses on developments in treatment of hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias. These include mechanisms of action and signaling pathways, their potential for new drug development, novel indications for older drugs, genetic approach to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as their guideline-based utilization in real-world patient populations. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues provide an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide for clinicians and researchers to navigate new products and therapies in cardiovascular pharmacology that will remain an essential and timeless resource.

Five Reasons to Publish Your Article in Cardiovascular Drugs and Therapy:

· High usage: Articles frequently downloaded from month to month

· Wide distribution: Institutions worldwide having full text access

· Efficient handling: 18 days between submission and first decision

· Fast publication: 17 days between acceptance and online publication

· International readership: North America, Asia, Europe, Middle East and South America

 

100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Yochai Birnbaum
Publishing model
Hybrid. Learn about publishing OA with us

Journal metrics

4.069 (2019)
Impact factor
3.197 (2019)
Five year impact factor
30 days
Submission to first decision
104 days
Submission to acceptance
121,548 (2019)
Downloads

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

View all updates

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1573-7241
Print ISSN
0920-3206
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. CNKI
  5. Chemical Abstracts Service (CAS)
  6. Current Contents/ Life Sciences
  7. Current Contents/Clinical Medicine
  8. Dimensions
  9. EBSCO Biomedical Reference Collection
  10. EBSCO Discovery Service
  11. EMBASE
  12. Elsevier Biobase
  13. Google Scholar
  14. Institute of Scientific and Technical Information of China
  15. Japanese Science and Technology Agency (JST)
  16. Journal Citation Reports/Science Edition
  17. Medline
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. Pathway Studio
  21. ProQuest Agricultural & Environmental Science Database
  22. ProQuest Biological Science Database
  23. ProQuest Biotechnology Research Abstracts
  24. ProQuest Central
  25. ProQuest Engineering
  26. ProQuest Environmental Science
  27. ProQuest Health & Medical Collection
  28. ProQuest Health Research Premium Collection
  29. ProQuest Materials Science and Engineering Database
  30. ProQuest Medical Database
  31. ProQuest Natural Science Collection
  32. ProQuest Pharma Collection
  33. ProQuest SciTech Premium Collection
  34. ProQuest Technology Collection
  35. ProQuest-ExLibris Primo
  36. ProQuest-ExLibris Summon
  37. Qinsight
  38. Reaxys
  39. SCImago
  40. SCOPUS
  41. Science Citation Index
  42. Science Citation Index Expanded (SciSearch)
  43. Semantic Scholar
  44. TD Net Discovery Service
  45. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature